SYRS (SYRS) Stock Price & Analysis
SYRS (SYRS) rose 0.00% to USD 0 as of September 8, 2026 at 09:02 UTC, according to Nexqual real-time market data.
SYRS last closed at USD 0; the session ranged USD 0–0 on volume of 904 shares. Market capitalization is —, with a 52-week range of USD 0–0.02 (PNK). Source: Nexqual, September 8, 2026 at 09:02 UTC.
Key Statistics (as of September 8, 2026 at 09:02 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.02 |
| Volume | 904 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (SYRS)
Nexqual's technical model rates SYRS "STRONG BUY" based on 5 bullish and 0 bearish signals across 129 daily candles, as of September 8, 2026 at 09:02 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.51 (neutral) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | USD 5.72 | ▲ 3.25% |
| CGEN | Compugen Ltd. | USD 2.59 | ▼ 1.52% |
| VCYT | Veracyte, Inc. | USD 42.53 | ▼ 5.24% |
| CALA | Calithera Biosciences, Inc. | USD 0 | ▲ 0% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:02 UTC. This page is informational and not investment advice.